Discover 1,933 paid clinical trials in Richardson, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,933
Diaphragmatic Hernia Research & Exploration, Advancing Molecular Science
for
Congenital Diaphragmatic Hernia
Location: Dallas TX, St Louis MO, Omaha NE, Chicago IL,
Sponsor: Columbia University
Sex: All
Age: 0+
Code: NCT00950118
Recruiting
Prognostic Value of Hyperpolarized 13C MRI for Clinical Myocardial Viability
Sponsor: University of Texas Southwestern Medical Center
Sex: All
Age: 20 - 70+
Code: NCT06047028
Recruiting
A Study to Evaluate Atumelnant in Adults With Congenital Adrenal Hyperplasia
for
Congenital Adrenal Hyperplasia,
Location: Dallas TX, Aurora CO, Atlanta GA, Chicago IL,
Sponsor: Crinetics Pharmaceuticals Inc.
Sex: All
Age: 18 - 70+
Code: NCT07144163
Phase 3, Recruiting
Study to Learn More About the Safety and Effectiveness of the Drug VITRAKVI During Routine Use in Patients With TRK Fusion Cancer Which is Locally Advanced or Spread From the Place Where it Started to Other Places in the Body
for
Locally Advanced or Metastatic Solid Tumor Harboring an NTRK Gene Fusion,
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
for
Pancreatic Neuroendocrine Tumor (pNET),
Location: Dallas TX, Metairie LA, St Louis MO, Birmingham AL,
Sponsor: Exelixis
Sex: All
Age: 18+
Code: NCT06943755
Phase 2, Phase 3, Recruiting
A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)
for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: Dallas TX, Tyler TX, San Antonio TX, Baton Rouge LA,
Sponsor: BeOne Medicines
Sex: All
Age: 18+
Code: NCT06943872
Phase 3, Recruiting
A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma
for
Metastatic Castration Resistant Prostate Cancer (mCRPC),
Location: Irving TX, Oklahoma City OK, San Antonio TX, Omaha NE,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT03460977
Phase 1, Recruiting
Substudy 01I: A Study of Investigational Agents in Participants With Previously Treated Stage IV Squamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-01I/KEYMAKER-U01I)
for
Lung Neoplasm
Location: Dallas TX, Lexington KY, Fairfax VA, Baltimore MD
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06780098
Phase 2, Recruiting
Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations
for
Non-Small-Cell Lung Cancer,
Location: Dallas TX, Houston TX, Aurora CO, Arlington Heights IL,
Sponsor: ArriVent BioPharma, Inc.
Sex: All
Age: 18+
Code: NCT07185997
Phase 3, Recruiting
A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine Therapy
for
Breast Cancer, Early Breast Cancer
Location: Irving TX, Pierre SD, Aberdeen SD, Winston-Salem NC
Sponsor: AstraZeneca
Sex: All
Age: 18 - 70+
Code: NCT05774951
Phase 3, Recruiting
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
for
Ovarian Neoplasms, Breast Neoplasms,
Location: Dallas TX, St Louis MO, Indianapolis IN, Madison WI,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT07213791
Phase 1, Recruiting
Optimization of Saturation Targets And Resuscitation Trial (OptiSTART)
for
Premature Infants, Bronchopulmonary Dysplasia,
Location: Dallas TX
Sponsor: University of Texas Southwestern Medical Center
Sex: All
Age: 0
Code: NCT05849077
Recruiting
Chemotherapy + Anakinra in Patients With Pancreatic Adenocarcinoma (PDAC)
for
Pancreatic Adenocarcinoma
Location: Dallas TX
Sponsor: Baylor Research Institute
Sex: All
Age: 18+
Code: NCT04926467
Phase 2, Recruiting
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
for
Advanced Malignant Solid Neoplasm,
Location: Dallas TX, Abilene TX, Oklahoma City OK, Houston TX,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 0+
Code: NCT05564377
Phase 2, Recruiting
Analysis of Graft Function Following Autologous Islet Transplantation
for
Chronic Pancreatitis
Location: Dallas TX
Sponsor: Baylor Research Institute
Sex: All
Age: 18+
Code: NCT03097185
Recruiting
A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)
for
Carcinoma, Non-Small-Cell Lung
Location: Dallas TX, Tyler TX, Shreveport LA, San Antonio TX,
Sponsor: Mirati Therapeutics Inc.
Sex: All
Age: 18+
Code: NCT06875310
Phase 3, Recruiting
A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
for
Lymphoma, Non-Hodgkin's, Lymphoma, Diffuse Large B-Cell,
Location: Dallas TX, Nashville TN, Denver CO, Atlanta GA,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT07226843
Phase 1, Recruiting
BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer Who Have Not Received Prior Treatment for Advanced or Metastatic Disease
for
HR+/HER2- Breast Cancer
Location: Dallas TX, Austin TX, Hot Springs AR, Springfield MO,